Prostate Cancer


ß-Carotene Supplementation for Patients with Low Baseline Levels and Decreased Risks of Total and Prostate Carcinoma 10-Year Outcome for Men with Localized Prostate Cancer Treated with External Radiation Therapy: Results of a Cohort Study. A comparison of External Beam Radiation Therapy versus Radical Prostatectomy for Patients with Low Risk Prostate Carcinoma Diagnosed, Staged, and Treated at a Single Institution A Prospective Study Of The Serum Prostate Specific Antigen Concentrations And Gleason Histologic Scores Of Black And White Men With Prostate Carcinoma A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer American Brachytherapy Society (ABS) Recommendations for Transperineal Permanent Brachytherapy of Prostate Cancer Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer Biochemical Failure does not Predict Overall Survival after Radical Prostatectomy for Localized Prostate Cancer: 10-year Results Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: A preliminary study Combined Androgen Blockade with Nonsteroidal Antiandrogens for Advanced Prostate Cancer: A Systematic Review Comparative Efficiency of Prostate-Specific Antigen Screening Strategies for Prostate Cancer Detection Comparison of Radiation Side-Effects of Conformal and Conventional Radiotherapy in Prostate Cancer: a Randomised Trial Cost-Effectiveness of Androgen Suppression Therapies in Advanced Prostate Cancer Detection of Prostate Cancer: Serendipity Strikes Again Does Prolonged Combined Androgen Blockade Have Survival Benefits Over Short-Term Combined Androgen Blockade Therapy? Extensive Biopsy Protocol Improves the Detection Rate of Prostate Cancer Health Outcomes after Prostatectomy or Radiotherapy for Prostate Cancer: Results From the Prostate Cancer Outcomes Study Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy andGoserelin Intensity-Modulated Radiotherapy As Primary Treatment For Prostate Cancer: Acute Toxicity In 114 Patients Laparoscopic Radical Prostatectomy: Preliminary Results Long-Term Results Of A Randomized Trial For The Treatment Of Stages B2 And C Prostate Cancer: Radical Prostatectomy Versus External Beam Radiation Therapy With A Common Endocrine Therapy In Both Modalities Osteoporosis in men treated with androgen deprivation therapy for prostate cancer Percentage of Free PSA in Black versus White Men for Detection and Staging of Prostate Cancer: A Prospective Multicenter Clinical Trial Post-treatment PSA </= 0.2 ng/mL Defines Disease Freedom After Radiotherapy for Prostate Cancer Using Modern Techniques Prostate Cancer And Supplementation With Alpha-Tocopherol And Beta-Carotene: Incidence And Mortality In A Controlled Trial Prostate cancer in African-American men: Outcome following radiation therapy with or without adjuvant androgen ablation Prostate Specific Antigen Bounce after Radioactive Seed Implantation Followed by External Beam Radiation for Prostate Cancer Radiation Therapy for Clinically Localized Prostate Cancer: A Multi-Institutional Pooled Analysis Radical Surgery versus Radiotherapy for Adenocarcinoma of the Prostate Second Primary Tumors after Prostate Carcinoma Seminal Vesicle-Sparing Radical Prostatectomy: A Novel Concept to Restore Early Urinary Continence Significance of the CAG Repeat Polymorphism of the Androgen Receptor Gene in Prostate Cancer Progression Six-month Androgen Suppression Plus Radiation Therapy vs. Radiation Therapy Alone for Patients with Clinically Localized Prostate Cancer Six-month Androgen Suppression Plus Radiation Therapy vs. Radiation Therapy Alone for Patients with Clinically Localized Prostate Cancer Temporarily Deferred Therapy (watchful waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen Era Testosterone Recovery Following Prolonged Adjuvant Androgen Ablation for Prostate Carcinoma The bicalutamide Early Prostate Cancer Program. Demography The Effect of Androgen Deprivation on the Early Changes in Prostate Volume Following Transperineal Ultrasound Guided Interstitial Therapy for Localized Carcinoma of the Prostate The Role of Androgen Deprivation in the Definitive Management of Clinically Localized Prostate Cancer Treated with Radiation Therapy Therapeutic Radiation in Patients With a Rising Post-Prostatectomy PSA Level Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer

Blogs

I wish u knew... Understanding prostate cancer screening
by Timothy J. Hampshire
December 06, 2012

Don't Assume You Understand
by Bob Riter
July 29, 2015

Related News

Change in Bone Scan Index Predicts Prostate CA Survival

Jan 13, 2012

On-treatment related changes in bone scan index prognostic for survival, independent of PSA


Under and Over Imaging Suspected in Prostate CA Care

Apr 22, 2015

Patients with higher PSA, shorter PSA doubling time more likely to have second scan


Volume CT Scans May Improve Lung-Cancer Workups

Aug 5, 2015

Growth of lung nodules may be indicator of clinically significant lung cancer